Goldman Sachs Highlights Corvus Pharmaceuticals as a Promising Oral Player in $24 Billion Atopic Dermatitis Market
Goldman sees Corvus as a buy: its oral eczema drug could rival Dupixent and grow into multiple diseases, boosting the stock potential.
NOTRELOAD AI
AxoGen Stock Jumps as Cigna Adds Coverage for Avance Nerve Graft in Breast Reconstruction
AxoGen shares rose after Cigna will cover its nerve graft from Apr 2026, helping more patients get nerve repair after surgery.
Higher Aluminum Prices Help Alcoa, But Q1 Shipments Hit by Delays and Disruptions
Alcoa posted mixed Q1 results: profits rose, sales and shipments fell, but it expects recovery and stronger performance in Q2.
Netflix Co-Founder Reed Hastings Steps Down After 29 Years as Q1 Results Smash Expectations
Reed Hastings leaves Netflix’s board after 30 years. Q1 beats expectations, but shares fall on Q2 outlook. Growth and ads drive strong results.
MeiraGTx Stock Drops After $100M Share Offering and Bota-Vec Buy from Johnson & Johnson
MeiraGTx stock fell after $100M share sale to raise cash. Money will fund gene therapy drugs and future launches.
Achieve Life Sciences Stock Jumps as New CEO and $354 Million Funding Fuel Launch of First New Quit-Smoking Pill in 20 Years
Achieve Life Sciences jumps after CEO change, funding news, and progress on smoking/vaping quit drug cytisinicline.